MASSIRONI, SARA

MASSIRONI, SARA  

DIPARTIMENTO DI MEDICINA E CHIRURGIA (SCHOOL OF MEDICINE AND SURGERY)  

Mostra records
Risultati 1 - 20 di 35 (tempo di esecuzione: 0.059 secondi).
Titolo Tipologia Data di pubblicazione Autori File
Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial 01 - Articolo su rivista 2018 Fagiuoli S.Massironi S. +
The changing face of chronic autoimmune atrophic gastritis: an updated comprehensive perspective 01 - Articolo su rivista 2019 Massironi, SInvernizzi, P +
COVID-19 in Patients With Inflammatory Bowel Disease: A Single-center Observational Study in Northern Italy 01 - Articolo su rivista 2020 Massironi S.Cristoferi L.Mauri M.Invernizzi P. +
Gastro-entero-pancreatic neuroendocrine neoplasia: The rules for non-operative management 01 - Articolo su rivista 2020 Massironi S.Invernizzi P. +
New and Emerging Systemic Therapeutic Options for Advanced Cholangiocarcinoma 01 - Articolo su rivista 2020 Massironi, SaraBidoli, PaoloInvernizzi, Pietro +
Endoscopic Findings in Patients Infected With 2019 Novel Coronavirus in Lombardy, Italy 01 - Articolo su rivista 2020 Massironi S.Bono F.Di Bella C.Invernizzi P. +
High rates of 30-day mortality in patients with cirrhosis and COVID-19 01 - Articolo su rivista 2020 Soria, AlessandroMassironi, SaraFagiuoli, StefanoLucà, MartinaInvernizzi, PietroBonfanti, Paolo +
Reply to: Correspondence on “High rates of 30-day mortality in patients with cirrhosis and COVID-19” 01 - Articolo su rivista 2020 Soria A.Bonfanti P.Fagiuoli S.Belli L. S.Massironi S.Invernizzi P. +
Understanding short bowel syndrome: Current status and future perspectives 01 - Articolo su rivista 2020 Massironi S.Invernizzi P.Braga M. +
Management of Asymptomatic Sporadic Nonfunctioning Pancreatic Neuroendocrine Neoplasms (ASPEN) ≤2 cm: Study Protocol for a Prospective Observational Study 01 - Articolo su rivista 2020 Massironi S.Invernizzi P. +
An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs 01 - Articolo su rivista 2021 Gerussi A.Carbone M.Invernizzi P.Casella G.Ciaccio A.Cristoferi L.Crosignani A.Fagiuoli S.Malinverno F.Mancuso C.Massironi S.Milani C.Ronca V.Strazzabosco M. +
Second primary neoplasms in patients with lung and gastroenteropancreatic neuroendocrine neoplasms: Data from a retrospective multi-centric study 01 - Articolo su rivista 2021 Massironi S.Dotto A.Invernizzi P. +
On-treatment serum albumin level can guide long-term treatment in patients with cirrhosis and uncomplicated ascites 01 - Articolo su rivista 2021 Fagiuoli S.Massironi S. +
X Chromosome Contribution to the Genetic Architecture of Primary Biliary Cholangitis 01 - Articolo su rivista 2021 Gerussi A.Ciaccio A.Cristoferi L.Malinverno F.Mancuso C.Massironi S.Milani C.O'Donnell S. E.Ronca V.Barisani D.Fagiuoli S.Crosignani A.Strazzabosco M.Carbone M.Duga S.Invernizzi P. +
Risk of preoperative understaging of duodenal neuroendocrine neoplasms: a plea for caution in the treatment strategy 01 - Articolo su rivista 2021 Invernizzi P.Massironi S. +
Impact of COVID-19 on inflammatory bowel disease practice and perspectives for the future 01 - Articolo su rivista 2021 Barisani, DInvernizzi, PMassironi, S +
DCLK1, a putative novel stem cell marker in human cholangiocarcinoma 01 - Articolo su rivista 2021 Ambrosino, ValeriaMassironi, SaraInvernizzi, Pietro +
Gastrinoma and Zollinger Ellison syndrome: A roadmap for the management between new and old therapies 01 - Articolo su rivista 2021 Invernizzi P.Massironi S. +
Clinical challenge for gastroenterologists–Gastrointestinal manifestations of systemic mastocytosis: A comprehensive review 01 - Articolo su rivista 2022 Scaravaglio M.Pagni F.Ceola S.Invernizzi P.Massironi S. +
Clinical treatment of cholangiocarcinoma: an updated comprehensive review 01 - Articolo su rivista 2022 Laffusa, AliceScaravaglio, MikiCristoferi, LauraCiaccio, AntonioCortinovis, Diego LuigiInvernizzi, PietroMassironi, Sara +